IPS interviews head of Cuban research team working to develop dengue vaccine

NewsGuard 100/100 Score
Nov 17 2011

Inter Press Service interviews Maria Guadalupe Guzman, head of the Pedro Kouri Institute (IPK) Department of Virology and director of the PAHO/WHO Collaborating Centre for the Study of Dengue and its Vector, who is leading of a team of Cuban researchers working to develop a vaccine against dengue. In the interview, Guzman discusses Cuba's contributions to the field of dengue research, the influence of climate change on the transmission of dengue, and differences in the four strains of the virus (Grogg, 11/15).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Medical Research News | Disease/Infection News

Tags: , , , , ,

Comments (0)

Suggested Reading

Novel vaccine approach targets AML and other blood cancers
New monoclonal antibody vaccine slashes malaria risk in children
Durable lymph-node expansion improves vaccine responses against tumors
New vaccine technology provides protection against broad range of coronaviruses in mice
Breakthrough vaccine strategy guides the immune system to generate HIV neutralizing antibodies
Increased emotional sensitivity linked to previous COVID-19 infection, new research suggests
Placental DNA methylation patterns altered by pregnancy air pollution exposure, research reveals
New Quartet nanocage vaccine shows promise against coronavirus variants

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
UT Health San Antonio leads effort for developing oral vaccine against chlamydia